WallStSmart

Broadcom Inc (AVGO)vsVivoPower PLC (VIVO)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Broadcom Inc generates 146072030% more annual revenue ($89.10B vs $61,000). AVGO leads profitability with a 42.9% profit margin vs 0.0%. AVGO earns a higher WallStSmart Score of 80/100 (A-).

AVGO

Exceptional Buy

80

out of 100

Grade: A-

Growth: 10.0Profit: 10.0Value: 6.3Quality: 7.0
Piotroski: 6/9Altman Z: 1.59

VIVO

Hold

36

out of 100

Grade: F

Growth: 5.3Profit: 5.0Value: 5.0Quality: 3.3
Piotroski: 3/9Altman Z: -9.98

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVGO6 strengths · Avg: 10.0/10
Market CapQuality
$1.56T10/10

Mega-cap, among the largest globally

PEG RatioValuation
0.3210/10

Growing faster than its price suggests

Return on EquityProfitability
38.4%10/10

Every $100 of equity generates 38 in profit

Profit MarginProfitability
42.9%10/10

Keeps 43 of every $100 in revenue as profit

Operating MarginProfitability
54.3%10/10

Strong operational efficiency at 54.3%

Revenue GrowthGrowth
85.5%10/10

Revenue surging 85.5% year-over-year

VIVO3 strengths · Avg: 9.3/10
Operating MarginProfitability
593000.0%10/10

Strong operational efficiency at 593000.0%

Revenue GrowthGrowth
47.6%10/10

Revenue surging 47.6% year-over-year

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

AVGO3 concerns · Avg: 3.3/10
Price/BookValuation
15.6x4/10

Trading at 15.6x book value

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

P/E RatioValuation
41.6x2/10

Premium valuation, high expectations priced in

VIVO4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$78.38M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AVGO

The strongest argument for AVGO centers on Market Cap, PEG Ratio, Return on Equity. Profitability is solid with margins at 42.9% and operating margin at 54.3%. Revenue growth of 85.5% demonstrates continued momentum.

Bull Case : VIVO

The strongest argument for VIVO centers on Operating Margin, Revenue Growth, Price/Book. Revenue growth of 47.6% demonstrates continued momentum.

Bear Case : AVGO

The primary concerns for AVGO are Price/Book, Altman Z-Score, P/E Ratio. A P/E of 41.6x leaves little room for execution misses.

Bear Case : VIVO

The primary concerns for VIVO are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

AVGO profiles as a growth stock while VIVO is a hypergrowth play — different risk/reward profiles.

AVGO carries more volatility with a beta of 1.48 — expect wider price swings.

AVGO is growing revenue faster at 85.5% — sustainability is the question.

AVGO generates stronger free cash flow (13.7B), providing more financial flexibility.

Bottom Line

AVGO scores higher overall (80/100 vs 36/100), backed by strong 42.9% margins and 85.5% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Broadcom Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Broadcom Inc. is an American designer, developer, manufacturer and global supplier of a wide range of semiconductor and infrastructure software products. Broadcom's product offerings serve the data center, networking, software, broadband, wireless, and storage and industrial markets.

Visit Website →

VivoPower PLC

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.

Want to dig deeper into these stocks?